Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy

BACKGROUND: Acute kidney injury (AKI) occurs frequently in hospitalized patients and has been associated with the administration of certain medications. Concerns have been raised in recent reports that the antibiotic combination of vancomycin and piperacillin/tazobactam (combV/P) may be more associa...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Res Notes
Главные авторы: Kim, Tiffany, Kandiah, Sheetal, Patel, Manish, Rab, Saira, Wong, Jordan, Xue, Wenqiong, Easley, Kirk, Anderson, Albert M.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4609063/
https://ncbi.nlm.nih.gov/pubmed/26476979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1518-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы